Sophisticated science? Check. cuRNA, one of the first two spinoffs from Scripps Florida, is based on research by Scripps Florida’s Claes Wahlestedt, a Swede who thinks he has found a breakthrough in the so-called upregulation of RNA. The company already has filed 80 patents.
Quirky name? Check. cuRNA’s moniker combines cure and RNA, or ribonucleic acid, the molecules that make proteins.
Altruistic chief executive officer? Check. cuRNA is run and bankrolled by Joe Collard, a Delray Beach millionaire who made his money founding a tech company.
Maha Akiki: Akiki's Daily: The Pharma Edition is out! http://t.co/ToLGEUaIw6 Stories via @healthcareos @flabiotechnews @mmaskaly
Florida Biotech: Contributed Tweets for @flabiotechnews are delivered by @RoundTeam https://t.co/pP63LB2CRP
Reiner Gentz: @UtopicaCronica @BioFlorida @flabiotechnews @anna_dunn12 @MaddiePellet @caiden_lynn @jordandominy Please follow back. Thanks.
Maha Akiki: Akiki's Daily: The Pharma Edition is out! http://t.co/ToLGEUaIw6 Stories via @sumeetkad @vaccineethics @flabiotechnews
Find us on Google+